Silencing TMPRSS13 can significantly suppress breast cancer progression both in vitro and in vivo by decreasing proliferation, enhancing apoptosis and inhibiting invasion, resulting in the inhibition of overall tumour burden and deficiency of detectable tumour growth (15). The gene discussed is TMPRSS13; the disease is neoplasm.